These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 25893930

  • 1. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P.
    Prostate; 2015 Aug 01; 75(11):1177-86. PubMed ID: 25893930
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M.
    J Clin Oncol; 2013 Feb 10; 31(5):523-9. PubMed ID: 23295793
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
    Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP.
    Cancer Epidemiol Biomarkers Prev; 2001 Aug 10; 10(8):861-8. PubMed ID: 11489752
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
    Bunker CH, McDonald AC, Evans RW, de la Rosa N, Boumosleh JM, Patrick AL.
    Nutr Cancer; 2007 Aug 10; 57(2):130-7. PubMed ID: 17571945
    [Abstract] [Full Text] [Related]

  • 7. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
    Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM.
    Cancer Prev Res (Phila); 2011 Nov 10; 4(11):1761-9. PubMed ID: 21896650
    [Abstract] [Full Text] [Related]

  • 8. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K, Li X, Du Y, Tang X, Arai S, Geng Y, Xi Y, Xu H, Zhou Y, Ma W, Zhang T.
    Oncotarget; 2017 May 30; 8(22):36674-36684. PubMed ID: 28415774
    [Abstract] [Full Text] [Related]

  • 9. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia.
    Joniau S, Goeman L, Roskams T, Lerut E, Oyen R, Van Poppel H.
    Urology; 2007 Jun 30; 69(6):1102-6. PubMed ID: 17572195
    [Abstract] [Full Text] [Related]

  • 10. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
    Mohanty NK, Saxena S, Singh UP, Goyal NK, Arora RP.
    Urol Oncol; 2005 Jun 30; 23(6):383-5. PubMed ID: 16301113
    [Abstract] [Full Text] [Related]

  • 11. Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial.
    Micali S, Territo A, Pirola GM, Ferrari N, Sighinolfi MC, Martorana E, Navarra M, Bianchi G.
    Arch Ital Urol Androl; 2017 Oct 03; 89(3):197-202. PubMed ID: 28969404
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
    Fleshner NE, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K, Farley A, Jansz K, Siemens DR, Trpkov K, Lacombe L, Gleave M, Tu D, Parulekar WR.
    J Clin Oncol; 2011 Jun 10; 29(17):2386-90. PubMed ID: 21537051
    [Abstract] [Full Text] [Related]

  • 14. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
    Milonas D, Auskalnis S, Skulcius G, Gudinaviciene I, Jievaltas M, Joniau S.
    World J Urol; 2017 May 10; 35(5):721-728. PubMed ID: 27644229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, Thompson I, Lippman SM, Lieberman R, Alberts D, Jarrard D, Coltman C, Greenwald P, Minasian L, Crawford ED.
    Cancer Epidemiol Biomarkers Prev; 2006 Aug 10; 15(8):1479-84. PubMed ID: 16896036
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
    Clark LC, Marshall JR.
    Urology; 2001 Apr 10; 57(4 Suppl 1):185-7. PubMed ID: 11295623
    [Abstract] [Full Text] [Related]

  • 19. Natural history of widespread high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: should we rebiopsy them all?
    Oderda M, Rosazza M, Agnello M, Barale M, Calleris G, Daniele L, Delsedime L, Falcone M, Faletti R, Filippini C, Giordano A, Marquis A, Marra G, Pacchioni D, Gontero P.
    Scand J Urol; 2021 Apr 10; 55(2):129-134. PubMed ID: 33410348
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.